TODD STRATEGY GROUP

Lobbying for KALEO · Pharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · $40,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Pharmacy

Prescription drug pricing. Medical countermeasure development and procurement.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem